Published in Heart on January 28, 2009
Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations. J Am Coll Cardiol (2011) 1.55
Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation (2013) 1.30
Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. Antioxid Redox Signal (2013) 1.07
Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.89
N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc (2013) 0.86
Statin Therapy for Primary Prevention of Atrial Fibrillation: Guided by CHADS2/CHA2DS2VASc Score. Korean Circ J (2014) 0.81
Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes. Indian J Med Res (2013) 0.79
Statins therapy can reduce the risk of atrial fibrillation in patients with acute coronary syndrome: a meta-analysis. Int J Med Sci (2013) 0.79
Prevention of atrial fibrillation: another good reason to recommend statins to women? Heart (2009) 0.77
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83
Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA (2006) 5.95
Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med (2002) 5.74
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation (2001) 5.49
Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation (1997) 5.16
Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation (1998) 5.11
Inflammation as a risk factor for atrial fibrillation. Circulation (2003) 4.95
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol (2005) 4.40
Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm (2006) 2.81
Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol (2005) 2.47
Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol (2007) 2.41
Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation (2002) 2.22
The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation. J Cardiovasc Electrophysiol (2007) 2.09
C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of an inflammatory process in paroxysmal atrial fibrillation. Acta Cardiol (2001) 1.99
Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol (2003) 1.98
Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol (2003) 1.90
Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol (2002) 1.89
Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke (2006) 1.86
Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest (2005) 1.85
The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation. Heart (2007) 1.84
Regional left atrial voltage in patients with atrial fibrillation. Heart Rhythm (2006) 1.84
New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation (2001) 1.83
Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials. J Am Coll Cardiol (2008) 1.66
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation (2005) 1.66
Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol (2006) 1.65
Effects of gender on cardiac arrhythmias. J Cardiovasc Electrophysiol (1998) 1.61
NOVACODE serial ECG classification system for clinical trials and epidemiologic studies. J Electrocardiol (1992) 1.59
Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg (2007) 1.55
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med (2006) 1.46
Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study. Am Heart J (2007) 1.42
Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation (2004) 1.41
Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol (1995) 1.32
Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol (1990) 1.20
Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics. Control Clin Trials (1998) 1.17
Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol (1993) 1.11
Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol (2004) 1.09
Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J (2005) 1.08
Women and coronary disease. Heart (2008) 1.02
Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology (2006) 0.97
Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Am Heart J (2007) 0.89
Comparison of frequency of new-onset atrial fibrillation or flutter in patients on statins versus not on statins presenting with suspected acute coronary syndrome. Am J Cardiol (2007) 0.88
Statins and polyunsaturated fatty acids for treatment of atrial fibrillation. Nat Clin Pract Cardiovasc Med (2008) 0.87
Statin use and recurrence of atrial fibrillation after successful cardioversion. Am Heart J (2007) 0.87
Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure. Am Heart J (2007) 0.87
Age and gender influences on rate and duration of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (1998) 0.84
Inflammation and atrial fibrillation: cause or effect? Heart (2008) 0.81
Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker. Clin Cardiol (2006) 0.79
CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol (1988) 15.40
Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science (1999) 7.57
Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet (1986) 7.35
Carcinogenicity of lipid-lowering drugs. JAMA (1996) 7.04
Factors associated with the health care utilization of homeless persons. JAMA (2001) 6.61
Expired air carbon monoxide and serum thiocyanate as objective measures of cigarette exposure. Am J Public Health (1977) 5.10
Health policy on blood cholesterol. Time to change directions. Circulation (1992) 4.71
Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science (2000) 4.57
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation (1977) 4.47
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2000) 4.29
The Stanford Five-City Project: design and methods. Am J Epidemiol (1985) 4.06
Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (2000) 4.05
Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol (1997) 3.66
Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol (2001) 3.36
Cholesterol screening in asymptomatic adults, revisited. Part 2. Ann Intern Med (1996) 3.30
Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials (1991) 3.30
Patient, center and geographic characteristics of nationally placed livers. Am J Transplant (2012) 3.16
Two entities in angiolipoma. A study of 459 cases of lipoma with review of literature on infiltrating angiolipoma. Cancer (1974) 3.14
Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med (1980) 2.96
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA (1995) 2.69
Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet (1977) 2.66
Comparison of biochemical and questionnaire estimates of tobacco exposure. Prev Med (1979) 2.65
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin Proc (1992) 2.64
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci U S A (2001) 2.61
Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. J Acquir Immune Defic Syndr (2001) 2.59
Use of T lymphocyte subset analysis in the case definition for AIDS. J Acquir Immune Defic Syndr (1993) 2.57
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J (1986) 2.55
Preventing the heterosexual spread of AIDS. Are we giving our patients the best advice? JAMA (1988) 2.54
The case against childhood cholesterol screening. JAMA (1990) 2.51
Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect Dis J (1991) 2.47
Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA (1992) 2.42
Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol (2004) 2.24
Predictors of maintaining cognitive function in older adults: the Health ABC study. Neurology (2009) 2.21
Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol (2001) 2.21
Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation (2001) 2.12
Decreased ankle/arm blood pressure index and mortality in elderly women. JAMA (1993) 2.06
HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet (2003) 2.02
The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS (1993) 2.00
Cost and health implications of cholesterol lowering. Circulation (1992) 2.00
Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis (2001) 1.88
Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA (1987) 1.86
HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA (1994) 1.79
Cholesterol in the elderly. Is it important? JAMA (1994) 1.78
The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease. Am J Epidemiol (1985) 1.74
Prevalence and correlates of herpes simplex infections. The population-based AIDS in Multiethnic Neighborhoods Study. JAMA (1992) 1.71
Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology (2011) 1.69
The impact of diuretic therapy on reported sexual function. Arch Intern Med (1991) 1.61
Dynamic complexes of beta2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem (1999) 1.60
Appropriate controls for reverse transcription polymerase chain reaction (RT-PCR) Br J Haematol (1994) 1.60
Images in cardiovascular medicine. Calcified amorphous tumor of the heart. Circulation (2008) 1.56
Voluntary screening for human immunodeficiency virus (HIV) infection. Weighing the benefits and harms. Ann Intern Med (1989) 1.56
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol (2001) 1.56
Depressive affect and survival among gay and bisexual men infected with HIV. Arch Intern Med (1996) 1.55
Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis (1994) 1.53
Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study. Ann Epidemiol (1996) 1.53
Total endovascular debranching of the aortic arch. Eur J Vasc Endovasc Surg (2011) 1.49
Goblet cell carcinoid of the appendix. Am J Surg (1994) 1.47
Effect of prolonged bed rest on bone mineral. Metabolism (1970) 1.47
Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol (1987) 1.43
Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants. Heart Rhythm (2012) 1.43
Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha. Br J Haematol (1995) 1.43
Culture and characterization of dental follicle cells from rat molars. Cell Tissue Res (1992) 1.41
Blood pressure in young blacks and whites: relevance of obesity and lifestyle factors in determining differences. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Circulation (1996) 1.40
Delayed effects of the military draft on mortality. A randomized natural experiment. N Engl J Med (1986) 1.39
Association between drug use patterns and HIV risks among homeless, runaway, and street youth in northern California. Drug Alcohol Depend (1998) 1.39
Cutaneous pseudosarcomatous polyp: a histological and immunohistochemical study. J Cutan Pathol (1996) 1.38
What happened to home HIV test collection kits? Intent to use kits, actual use, and barriers to use among persons at risk for HIV infection. AIDS Care (2002) 1.37
Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol (1995) 1.35
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther (2010) 1.35
The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. J Infect Dis (1994) 1.34
Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc (1995) 1.32
Home collection for frequent HIV testing: acceptability of oral fluids, dried blood spots and telephone results. HIV Early Detection Study Group. AIDS (2000) 1.32
Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. J Chronic Dis (1977) 1.31
The rightward gas vesicle operon in Halobacterium plasmid pNRC100: identification of the gvpA and gvpC gene products by use of antibody probes and genetic analysis of the region downstream of gvpC. J Bacteriol (1993) 1.28
Correlates of condom failure in a sexually active cohort of men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.28
Wild-type gas vesicle formation requires at least ten genes in the gvp gene cluster of Halobacterium halobium plasmid pNRC100. J Bacteriol (1994) 1.27
Effects of the multiple risk factor intervention trial smoking cessation program on pulmonary function. A randomized controlled trial. West J Med (1992) 1.26
Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon carcinoma. Mol Pathol (2002) 1.25
Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. Arch Intern Med (1998) 1.24
Antibiotics in acute bronchitis: a meta-analysis. Am J Med (1999) 1.24
The status of hypertriglyceridemia as a risk factor for coronary heart disease. Clin Lab Med (1989) 1.24
Television viewing and cardiovascular risk factors in young adults: the CARDIA study. Ann Epidemiol (1996) 1.23
Postural hypotension and postural dizziness in elderly women. The study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. Arch Intern Med (1992) 1.23
Hip osteoarthritis and dysplasia in Chinese men. Ann Rheum Dis (1995) 1.21
Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA (2000) 1.21
Changes in HIV-related behaviors among heterosexual alcoholics following addiction treatment. Drug Alcohol Depend (1997) 1.21
Normal ranges for vertebral height ratios and prevalence of vertebral fracture in Hong Kong Chinese: a comparison with American Caucasians. J Bone Miner Res (1996) 1.20
Computed tomographic mammography using a conventional body scanner. AJR Am J Roentgenol (1982) 1.19
Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone. Am J Cardiol (1985) 1.19
Age-related hyperkyphosis, independent of spinal osteoporosis, is associated with impaired mobility in older community-dwelling women. Osteoporos Int (2010) 1.19
Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999. J Acquir Immune Defic Syndr (2001) 1.17
Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics. Control Clin Trials (1998) 1.17
Seismic evidence for widespread western-US deep-crustal deformation caused by extension. Nature (2010) 1.17